Streetbeat News

Earnings

NEE

SRE

WTRG

Wall Street's most accurate analysts recommend buying three utilities stocks with over 3% dividend yields: NextEra Energy, Inc. (NEE), Essential Utilities, Inc. (WTRG), and Sempra (SRE). These recommendations are based on their high dividend yields, recent analyst ratings, and significant company news such as earnings reports and regulatory updates.

Portfolio Pulse from Avi Kapoor

April 04, 2024 | 11:13 am

STAA

STAAR Surgical reported preliminary Q1 net sales exceeding $77M, surpassing estimates of $72.134M, and now anticipates FY24 net sales at the higher end of the $335M-$340M range. U.S. ICL sales hit a record $5M for the quarter. The company's cash and equivalents stood at approximately $248M, with accounts receivable at $70M as of March 29, 2024. STAAR Surgical will discuss detailed Q1 results and FY24 outlook on its earnings call around May 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:11 am

ANGO

AngioDynamics shares surged following the announcement of its Q3 FY2024 earnings, accompanied by the issuance of FY2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:09 am

GRYP

Gryphon Digital Mining, Inc. (NASDAQ:GRYP) announced its March 2024 operational update, highlighting the production of approximately 45 bitcoin, valued at around $3.1 million. The company, which operates on 100% renewable energy, achieved a new record in average self-mining hashing power of 912 PH/s and a bitcoin efficiency of 49 BTC/EH. Gryphon also initiated a machine upgrade program with the purchase of Bitmain S21 200 TH/s machines and reported having 59 bitcoin in its treasury as of March 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:09 am

ANGO

AngioDynamic forecasts a significant improvement in its financial performance for FY2024, expecting a gross margin of 52%-54% and an adjusted EPS of $0.54 to $0.58, which notably exceeds the consensus estimate of $(0.43).

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:07 am

CVAC

GSK

CureVac N.V. announced interim Phase 2 data from its seasonal influenza vaccine development program, conducted in collaboration with GSK. The vaccine candidate, designed for broad antigen coverage, encodes antigens for all four WHO-recommended flu strains.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:07 am

LEVI

Levi Strauss shares surged following the announcement of their Q1 financial results, which exceeded expectations. Additionally, the company has increased its adjusted EPS guidance for 2024, signaling confidence in its future performance.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:06 am

ANGO

AngioDynamics reported Q3 adjusted EPS of $(0.16), missing the $(0.13) estimate, and sales of $75.18M, missing the $75.73M estimate. This represents a significant decrease in performance compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:02 am

SMPL

Simply Good Foods (NASDAQ:SMPL) reported Q2 adjusted EPS of $0.40, surpassing the $0.38 estimate, marking a 25% year-over-year increase. However, their sales of $312.20M fell short of the $316.88M estimate, though still up 5.26% from last year.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:02 am

SMG

Scotts Miracle-Gro Co (SMG) anticipates a second-quarter net leverage ratio of approximately 7 times adjusted EBITDA, an improvement from its first-quarter ratio and below the second-quarter maximum of 7.75 times.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 10:57 am